List view / Grid view

Dr Amy Pooler (Senior Vice President of Research & Development at Life Edit)

 

article

Allele-selective gene editing: a breakthrough in Huntington’s disease treatment

Huntington's disease remains a major challenge, but allele-selective gene editing…

8 May 2025 | By

Huntington's disease remains a major challenge, but allele-selective gene editing offers new hope. By targeting only the mutant gene, this approach could provide a one-time, durable treatment. Life Edit’s Dr Amy Pooler reveals how this innovative therapy could reshape HD treatment.